Publications & Works

Publication Network
Articles 35
All (35)
SCI-E, SSCI, AHCI (25)
SCI-E, SSCI, AHCI, ESCI (32)
ESCI (7)
Scopus (34)
TRDizin (6)

1. The evaluation of miRNA-204 and miRNA-652-3p as serum biomarkers for endometrial cancer diagnosis and prognosis

Minareci Y., Sozen H., TOYRAN A., Tosun O. A., KÜÇÜKGERGİN C., GENÇ İ., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.36, no.2, 2026 (SCI-Expanded, Scopus) Sustainable Development

2. Serum lncRNA HOTAIRM1, but not miR-182-5p, as a Potential Non-Invasive Biomarker for Endometrial Cancer

Ulusoy H. E., Minareci Y., Kucukgergin C., Aydin A. F., Sozen H., Efe M. A., et al.
Clinical and Experimental Obstetrics and Gynecology , vol.53, no.2, 2026 (SCI-Expanded, Scopus) Creative Commons License Sustainable Development

3. Diagnostic utility of serum human epididymis protein 4, endocan, sialyl-tn, and neopterin in endometrial cancer

TOYRAN A., Minareci Y., Sozen H., Tosun O. A., KÜÇÜKGERGİN C., Aydin F., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.36, no.2, 2026 (SCI-Expanded, Scopus)

4. Comparison of disease-free survival, overall survival, and complications between patients with advanced ovarian cancer receiving neoadjuvant systemic chemotherapy with or without HIPEC

Durak D. K., TOYRAN A., Minareci Y., Sozen H., TOPUZ S., Salihoglu M. Y.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.36, no.2, 2026 (SCI-Expanded, Scopus) Sustainable Development

5. Serum human epididymis protein 4, endocan, sialyl-Tn, and neopterin in endometrial cancer: a prospective case–control study

Toyran A., Minareci Y., Sözen H., Kucukgergin C., Aydın A. F., GENÇ İ., et al.
Revista da Associacao Medica Brasileira , vol.72, no.4, 2026 (SCI-Expanded, Scopus) Creative Commons License

6. Serum expression levels of HOTAIR and miR-646 in endometrial cancer.

Harismunandar R., Karpuzoğlu H., Minareci Y., Sözen H., Topuz S., Küçükgergin C., et al.
Oncology letters , vol.31, no.2, pp.90, 2025 (SCI-Expanded, Scopus) Sustainable Development

7. Evaluation of total retroperitoneal en-bloc resection of multivisceral-peritoneal packet (TROMP) in advanced ovarian cancer: A single-center cohort study.

Sozen H., Minareci Y., Toyran A., Tutar E., AHMED M. A., Topuz S., et al.
Gynecologic oncology , vol.201, pp.102-108, 2025 (SCI-Expanded, Scopus)

8. Predictors and treatment of ısolated recurrence in vulvar cancer confined to the vulva or perineum

Güngördük K., Demirkiran F., Khatib G., Öz M., GÜLSEREN V., Minareci Y., et al.
Journal of cancer research and therapeutics , vol.21, no.5, pp.1059-1063, 2025 (SCI-Expanded, Scopus) Sustainable Development

9. Carbon dye versus indocyanine green for sentinel lymph node mapping in endometrial cancer: a prospective dual-center study

Minareci Y., Sozen H., Bayram A., Hacioglu B. A., Yuvanc H. O., Murdan R., et al.
International Journal of Gynecological Cancer , vol.35, no.6, 2025 (SCI-Expanded, Scopus)

10. Reflections on the HORSE Trial: Hyperthermic Intraperitoneal Chemotherapy, BRCA Status, and Clinical Implications

Sözen H., Minareci Y., Toyran A., Albayrak M., Topuz S., Salihoglu Y.
Journal of Clinical Oncology , vol.43, no.16, pp.1932, 2025 (SCI-Expanded, Scopus)

11. Predicting recurrence in adult granulosa cell tumors: the role of Ki67, p53, and TERT mutations

Bayram A., Bagbudar S., Yılmaz İ., Sozen H., Minareci Y., Altay A. Y., et al.
Archives of Gynecology and Obstetrics , vol.311, no.2, pp.415-421, 2025 (SCI-Expanded, Scopus)

12. CHIPOR: gaps in recurrent ovarian cancer management

Toyran A., Sozen H., Minareci Y., Topuz S., Salihoglu Y.
The Lancet Oncology , vol.26, no.2, 2025 (SCI-Expanded, Scopus) Sustainable Development

13. Prognostic value of chemotherapy response score in advanced ovarian cancer: a single-center retrospective analysis

Sözen H., Minareci Y., Toyran A., YALÇIN İ., Önder S., Bayram A., et al.
Sao Paulo medical journal = Revista paulista de medicina , vol.143, no.6, 2025 (SCI-Expanded, Scopus) Sustainable Development

14. Prognostic Value of p16INK4A and Ki67 Co-expression in Patients with Vaginal Intraepithelial Neoplasia

Minareci Y., AK N., Bayram A., Tosun O. A., Murdan R., Onder S., et al.
INDIAN JOURNAL OF GYNECOLOGIC ONCOLOGY , vol.22, no.2, 2024 (ESCI)

15. The evaluation of miR-1181 and miR-4314 as serum microRNA biomarkers for epithelial ovarian cancer diagnosis and prognosis.

Minareci Y., Ak N., Sozen H., Tosun O. A., Kucukgergin C., Aydin F., et al.
Molecular biology reports , vol.51, no.1, pp.515, 2024 (SCI-Expanded, Scopus) Sustainable Development

16. Sentinel lymph node biopsy with carbon dye in endometrial cancer: a single center, prospective cohort study

Minareci Y., Sozen H., Altinkara Hacioglu B., Yuvanc H. O., Topuz S., Salihoglu M. Y.
Surgical Endoscopy , vol.38, no.3, pp.1608-1616, 2024 (SCI-Expanded, Scopus) Sustainable Development

17. Comparison of Veress needle and direct trocar technique during laparoscopic initial entry via Palmer's point

MİNARECİ Y., Yuvanc H. O.
CESKA GYNEKOLOGIE-CZECH GYNAECOLOGY , vol.89, no.6, pp.451-458, 2024 (ESCI, Scopus) Sustainable Development

18. RECONSTRUCTION OPTIONS FOR CHALLENGING PERINEAL DEFECTS ZORLAYICI PERINE DEFEKTLERINDE ONARIM SEÇENEKLERI

Aksöyler D., Nergizogullari M. C., Yalçin Y., Kozanoglu E., Akalin B. E., Ercan L. D., et al.
Istanbul Tip Fakultesi Dergisi , vol.87, no.4, pp.275-282, 2024 (ESCI, Scopus, TRDizin)

19. MICRORNA 1181 AND 4314 AS PROMISING BIOMARKERS FOR EPITHELIAL OVARIAN CANCER DIAGNOSIS AND PROGNOSIS

MİNARECİ Y., AK N., SÖZEN H., Tosun O. A., KÜÇÜKGERGİN C., AYDIN F., et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , 2023 (SCI-Expanded, Scopus)

20. Central nervous system metastasis in gynecologic cancers: Seeking the prognostic factors

Minareci Y., AK N., Tosun O. A., Sozen H., SAİP P. M., Topuz S., et al.
Journal of Cancer Research and Therapeutics , vol.19, 2023 (SCI-Expanded, Scopus)

21. Prolongation of Neoadjuvant Chemotherapy before Surgery: Seeking the Optimal Number of Cycles in Serous Ovarian Cancer

Minareci Y., Sozen H., Ak N., Tosun O. A., Saip P., Salihoglu M. Y., et al.
CHEMOTHERAPY , vol.67, pp.1-11, 2022 (SCI-Expanded, Scopus) Sustainable Development

22. Predictors of high-grade residual disease after repeat conization in patients with positive surgical margins

Minareci Y., AK N., Tosun O. A., Sozen H., Disci R., Topuz S., et al.
Ginekologia polska , vol.93, no.12, pp.962-967, 2022 (Scopus)

23. Preoperative Minimal-Residue Diet Versus Fasting Alone in Minimally Invasive Gynecologic Surgery

Minareci Y., Portakal S.
JOURNAL OF GYNECOLOGIC SURGERY , vol.37, pp.485-490, 2021 (ESCI)

24. Skeletal system as a rare metastatic site in patients with ovarian carcinoma

Ak N., Minareci Y., Saip P.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , vol.31, no.8, pp.1125-1131, 2021 (SCI-Expanded, Scopus) Sustainable Development

25.

MINARECI Y., TOSUN Ö., Ak N., SÖZEN H., TOPUZ S., SALIHOGLU M. Y.
Kocaeli Tıp Dergisi , vol.10, no.3, pp.217-224, 2021 (Peer-Reviewed Journal) Creative Commons License

26. rFSH Versus Transvaginal Hydrolaparoscopic Ovarian Drilling in Patients with Polycystic Ovary Syndrome Resistant to Ovulation Induction

Minareci Y., Portakal S.
JOURNAL OF REPRODUCTIVE MEDICINE , vol.66, pp.40-46, 2021 (SCI-Expanded, Scopus)

27. Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma

Naziye A. K., Paksoy N., Ferhatoglu F., Aydin E., Dogan I., Bektas E., et al.
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.36, pp.438-445, 2021 (ESCI)

28. A retrospective clinical analysis of hyperthermic intraperitoneal chemotherapy in gynecological cancers: Technical details, tolerability, and efficacy Jinekolojik kanserlerde hipertermik intraperitoneal kemoterapinin retrospektif olarak değerlendirilmesi: Teknik detay, tolerabilitesi ve etkilinliği

Minareci Y., Tosun O. A., Sozen H., Topuz S., Salihoglu M. Y.
Medeniyet Medical Journal , vol.35, no.3, pp.202-211, 2020 (Scopus, TRDizin) Creative Commons License Sustainable Development

29. Clinicopathologic and survival results in serous endometrium carcinoma and subgroup analysis for mixed serous and pure serous histology

Kaban A., Topuz S., Sozen H., Minareci Y., Salihoglu Y.
JOURNAL OF THE TURKISH-GERMAN GYNECOLOGICAL ASSOCIATION , vol.19, no.1, pp.23-28, 2018 (ESCI) Sustainable Development

30. Maternal and fetal adropin levels in gestational diabetes mellitus

Celik E., YILMAZ E., Celik O., Ulas M., TÜRKÇÜOĞLU I., KARAER A., et al.
JOURNAL OF PERINATAL MEDICINE , vol.41, no.4, pp.375-380, 2013 (SCI-Expanded, Scopus) Sustainable Development

31. Maternal and fetal serum orexin-A levels in gestational diabetes mellitus

YILMAZ E., CELIK O., CELIK N., CELIK E., TURKCUOGLU I., SIMSEK Y., et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH , vol.39, no.1, pp.139-145, 2013 (SCI-Expanded, Scopus) Sustainable Development

32. A comparative study on oxidative and antioxidative markers of serum and follicular fluid in GnRH agonist and antagonist cycles

Celik E., Celik O., Kumbak B., YILMAZ E., TÜRKÇÜOĞLU I., Simsek Y., et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS , vol.29, no.11, pp.1175-1183, 2012 (SCI-Expanded, Scopus)

33. Meigs' syndrome with elevated serum CA125: Case report and review of the literature Serum CA125 Yüksekli̇ǧi̇ i̇le Bi̇rli̇kte Olan Mei̇gs Sendromu: Olgu Sunumu Ve Li̇teratürün Gözden Geçi̇ri̇lmesi̇

YILMAZ E., Tanrikut E., KARAER A., ŞImşek Y., Çelik Ö., Minareci Y.
Turk Jinekoloji ve Obstetrik Dernegi Dergisi , vol.9, pp.22-25, 2012 (ESCI, Scopus, TRDizin)

34. Changes in serum obestatin, preptin and ghrelins in patients with Gestational Diabetes Mellitus

Baykus Y., Gurates B., Aydin S., Celik H., Kavak B., Aksoy A., et al.
CLINICAL BIOCHEMISTRY , vol.45, no.3, pp.198-202, 2012 (SCI-Expanded, Scopus) Sustainable Development

35. Surgical termination of pregnancy: evaluation of 14,903 cases.

AKTUN H., CAKMAK P., MOROY P., Minareci Y., YALCIN H., MOLLAMAHMUTOGLU L., et al.
Taiwanese journal of obstetrics & gynecology , vol.45, pp.221-4, 2006 (SCI-Expanded, Scopus)
Papers Presented at Peer-Reviewed Scientific Conferences 5

1. Serum miR-181-5p, miR-214-3p, and miR-223-3p expression in epithelial ovarian cancer.

AK N., Baspinar S. N., KÜÇÜKGERGİN C., Minareci Y., Sozen H., TOPUZ S., et al.
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, United States Of America, 29 May - 02 June 2026, vol.44, (Summary Text)

2. İleri Evre Over Kanserinde Kemoterapi Yanıt Skorunun Prognostik Değeri Tek Merkez Analizi.

SÖZEN H., MİNARECİ Y., TOYRAN A., YALÇIN İ., ÖNDER S., BAYRAM A., et al.
TÜRK JİNEKOLOJİK ONKOLOJİ DERNEĞİ & SERVİKAL PATOLOJİLER VE KOLPOSKOPİ DERNEĞİ ULUSAL KONGRESİ, Ankara, Turkey, 5 - 07 December 2024, (Summary Text)

3. Investigation of mirna-193b Expression and Stathmin 1 Level in Serum of Patients with Epithelial Ovary Cancer

Örskaya H. H., Minareci Y., Küçükgergin C., Aydin A. F., Salihoğlu M. Y., Sözen H., et al.
XXXIII. WASPaLM World Congress and XXIV. National Clinicial Biochemistry Congress, Antalya, Turkey, 16 - 20 October 2024, pp.94, (Summary Text)

4. MICRORNA 1181 AND 4314 AS PROMISING BIOMARKERS FOR EPITHELIAL OVARIAN CANCER DIAGNOSIS AND PROGNOSIS

Minareci Y., Ak N., Sözen H., Tosun Ö., Küçükgergin C., Aydın A. F., et al.
ESGO 2023 European Congress on Gynaecological Oncology, İstanbul, Turkey, 28 September - 01 October 2023, vol.33, pp.242, (Summary Text)

5. ENDOMETRİUM KANSERİNDE SERUM HOXB-AS1 GEN EKSPRESYONUNUN ETKİSİ

Kılınç S., Bingül İ., Küçükgergin C., Minareci Y., Sözen H., Topuz S., et al.
Uluslararası Katılımlı XXIII. Ulusal Klinik Biyokimya Kongresi, Antalya, Turkey, 27 - 30 April 2023, pp.154, (Summary Text) Sustainable Development
Metrics

Publication

40

Publication (WoS)

33

Publication (Scopus)

34

Citation (WoS)

131

H-Index (WoS)

5

Citation (Scopus)

162

H-Index (Scopus)

5

Citation (Sum Other)

30

Project

7

Open Access

4
UN Sustainable Development Goals
SDG 3: GOAL 3: GOOD HEALTH AND WELL-BEING
SDG 5: GOAL 5: GENDER EQUALITY
SDG 16: GOAL 16: PEACE, JUSTICE AND STRONG INSTITUTIONS